A carregar...

Rethinking cancer clinical trials for COVID-19 and beyond

The risks posed to patients with cancer by the current COVID-19 pandemic demand rapid structural changes in healthcare delivery, with many positive changes likely to continue long term. An immediate critical reassessment of trial methodology based on clinical and scientific priorities is essential t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Nat Cancer
Main Authors: Doherty, Gary J., Goksu, Mehmet, de Paula, Bruno H. R.
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group US 2020
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7258610/
https://ncbi.nlm.nih.gov/pubmed/35121973
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s43018-020-0083-x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!